FRI0194 INTEGRATED SAFETY PROFILE OF ATACICEPT FROM ALL CLINICAL STUDIES TO DATE
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.703
Abstract: Background: We conducted an integrated analysis of pooled safety data from all 17 atacicept clinical studies across multiple indications to date. Objectives: To characterize the overall safety profile of atacicept. Methods: Analyses were based on… read more here.
Keywords: exposure adjusted; infection; emd serono; current employees ... See more keywords
POS0663 THE USE OF EXPOSURE-ADJUSTED EVENT RATES VERSUS EXPOSURE-ADJUSTED INCIDENCE RATES IN ADVERSE EVENT REPORTING: INSIGHTS FROM FILGOTINIB INTEGRATED SAFETY DATA IN RHEUMATOID ARTHRITIS
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2022-eular.138
Abstract: Reporting of treatment-emergent adverse events (TEAEs) in rheumatoid arthritis (RA) clinical trials can be summarized as exposure-adjusted incidence rates (EAIRs) or exposure-adjusted event rates (EAERs). Censored EAIR (EAIR), weighing exposure up to a patient’s first… read more here.
Keywords: event; safety data; eair; exposure adjusted ... See more keywords